$TXMD So many people with short term vision. Where is the stock when Imvexxy revenues are 250 million a year, Bijuva is at 50 million and Annovera is at 400 million...24 months doesn’t seem so far away. Have a vision people. I don’t know what the value will be when that happens but I’ll bet it’s a nice return from the 3.85 levels today. It’s always easy to cut spend if need be too. Not worried about txmd at these levels.
View original message